HomeAI · summaries
Storia in 2 fonti
The China debate gets louder in Washington
A boom in GLP-1s and health care costs, AI-designed hair growth drugs, and more biotech news from The Readout
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
endpoints.news
BIO board spoke with national security, health officials on China, CEO says
BIO makes China political strategy a top priority as US weighs outbound investment limits; CEO Crowley says biotech may fall under COINS Act.
- ·
statnews.com
At BIO, a glimpse behind Lilly and Chai’s partnership
RIP Sangamo, onshoring with drug manufacturing, and more biotech news from The Readout
